Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01216709
Other study ID # Iron absorption in infants
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 2010
Est. completion date June 2012

Study information

Verified date March 2020
Source Umeå University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Iron deficiency (ID) affects up to 25% of Swedish infants and severe ID is associated with cognitive and behavioral problems. To avoid this, iron supplements or iron-fortified infant foods are recommended for infants. However, the optimal iron dose and mode of delivery have not yet been established. This is a concern as excessive iron intake may impair growth and increase morbidity in iron-sufficient infants. Previous studies have suggested that iron-fortified foods may have different effects than iron supplements. In this study, the investigators will investigate whether the mode of iron administration (supplementation vs. fortification) and the amount consumed (high intakes vs. low intakes) affect iron absorption, iron utilization, and zinc absorption in healthy term non-iron-deficient 6-month-old infants.


Recruitment information / eligibility

Status Completed
Enrollment 72
Est. completion date June 2012
Est. primary completion date June 2012
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 6 Months to 7 Months
Eligibility Inclusion Criteria:

- 6-7 months of age at the start of intervention

- healthy at enrollment

- full-term (>37 gestational weeks at birth)

- birth weight >2500 g

- predominantly bottle-fed at recruitment

Exclusion Criteria:

- iron deficiency at enrollment

- previous or current use of iron supplements

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
ferrous sulfate
6.3 mg iron from iron drops and 0.3 mg iron from infant formula with no added iron (0.5 mg iron/L) for 45 days
Other:
iron-fortified infant formula (12.4 mg iron/L)
6.6 mg iron from iron-fortified infant formula (12.4 mg iron/L) for 45 days
iron-fortified infant formula (2.3 mg iron/L)
1.2 mg iron from iron-fortified infant formula (2.3 mg iron/L) for 45 days

Locations

Country Name City State
Sweden Department of Clinical Sciences, Pediatrics, Umeå University Hospital Umeå

Sponsors (3)

Lead Sponsor Collaborator
Umeå University Swiss Federal Institute of Technology, University of California, Davis

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Primary iron absorption 1 month after enrollment
Secondary indicators of iron metabolism, growth, and oxidative stress 1 month and 1.5 months after enrollment
Secondary zinc absorption 1 month after enrollment
See also
  Status Clinical Trial Phase
Completed NCT01162798 - Preterm Infant Growth N/A
Completed NCT00808756 - Study on Fermentable Carbohydrates in Healthy Infants N/A
Completed NCT00355654 - Study to Compare Booster Vaccination With Pediacel® to Infanrix® Hexa When Both Are Co-Administered With Prevenar® Phase 3
Recruiting NCT06032494 - Investigating Changes in Vital Signs in Neonates
Not yet recruiting NCT05914324 - Outpatient Pediatric Pulse Oximeters in Africa N/A
Completed NCT04523441 - Early Support and Physiotherapy for Children and Their Motor Skills
Completed NCT02441296 - Carbohydrate and Metabolism: a Pilot Study N/A
Completed NCT00507676 - Lung Function and Structure in Healthy Infants and Infants With Recurrent Wheezing N/A
Recruiting NCT05072626 - High Medium-chain Triglyceride Nutritional Support in Infants With Biliary Atresia
Completed NCT04536194 - Dopamine Versus Norepinephrine Under General Anesthesia Phase 3
Recruiting NCT04598061 - IV Dexmedetomidine as Spinal Anesthesia Adjuvant in Infants
Completed NCT03567031 - Impact of CO2 on Cerebral Blood Flow in Infants Less Than 6 Months During General Anaesthesia N/A
Completed NCT02366780 - Breast Milk Content Expressed Manually Compared to Electric Pump N/A
Terminated NCT04641000 - The Alberta BLOOM Long Term Follow Up Study
Completed NCT02580123 - Smile-Kids: Study on Complementary Feeding Transition N/A
Completed NCT00294294 - Study Evaluating Treatment of Fever in Children Who Have Been Vaccinated With Prevenar and Infanrix Hexa Phase 4
Recruiting NCT04967118 - Neonatal Pain Management and Pain Monitoring Using New Methods N/A
Completed NCT03025178 - Optimal Insertion Depth of Left Internal Jugular Vein Catheter in Infants N/A
Completed NCT02722759 - Haemoglobin Measurement for Babies N/A
Recruiting NCT01147601 - Topical Timolol 0.5% Solution for Proliferating Infantile Hemangiomas Phase 0